EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia



RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia



Clinical Biochemistry 46(7-8): 579-583



We examined RAS mutational status and correlated this with presenting morphology, cytogenetics, clinical outcome and other gene aberrations in a large cohort of Chinese acute myeloid leukemia (AML) patients. N-RAS and K-RAS were screened for mutations at hot-spot codons 12, 13 and 61 using high resolution melting analysis (HRMA) and direct DNA sequencing in 504 Chinese AML patients and their clinical relevance was analyzed. The frequencies of mutations of N-RAS and K-RAS were 9.7% (49/504) and 2.9% (15/504), respectively. c.35G>A (rs121913237: G>A; p.Gly12Asp and rs121913529: G>A; p.Gly12Asp) and c.38G>A (rs121434596: G>A; p.Gly13Asp and rs112445441: G>A; p.Gly13Asp) were the most common base substitutions (46% in N-RAS and 60% in K-RAS, respectively). AML patients with RAS mutations presented significantly higher white blood cell count (WBC) at diagnosis than those without mutations (p<0.001). RAS mutations were underrepresented in patients with t(15;17) (2.9%, p=0.01), while overrepresented in cases with abn11q23 (50%, p=0.002) and inv(16) (66.6%, p=0.04). In the FAB subtypes M4 and M5, RAS mutations were more frequent (21.6% and 20.6%, respectively) than they were in other subtypes (7.5%, p=0.006 and 0.005, respectively). FLT3-ITD and RAS mutation were rarely coexistent (p=0.03). RAS mutation didn't influence overall survival (OS) either in the entire cohort or within some defined subgroups. RAS mutations are associated with some biologically specific subtypes of AML but don't impact clinical outcome in Chinese patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333386

Download citation: RISBibTeXText

PMID: 23313659

DOI: 10.1016/j.clinbiochem.2012.12.022



Related references

RAS mutation analysis in 504 Chinese patients with acute myeloid leukemia. 2013

Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients. Leukemia & Lymphoma 2018: 1-8, 2018

Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients. American Journal of Hematology 89(9): 874-881, 2014

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Annals of Hematology 91(4): 519-525, 2012

Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry: -, 2018

Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis. Clinica Chimica Acta 479: 25-37, 2018

Absence of miR-142 mutation in Chinese patients with acute myeloid leukemia. Leukemia & Lymphoma 55(12): 2961-2962, 2015

SF3B1 mutation is a rare event in Chinese patients with acute and chronic myeloid leukemia. Clinical Biochemistry 46(7-8): 701-703, 2013

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 118(20): 5593-5603, 2012

Mutation profile and associated clinical features in Chinese patients with cytogenetically normal acute myeloid leukemia. International Journal of Laboratory Hematology: -, 2018

Cytogenetic and genetic mutation features of de novo acute myeloid leukemia in elderly Chinese patients. Asian Pacific Journal of Cancer Prevention 15(2): 895-898, 2014

A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia--evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients. Cancer Genetics 204(8): 430-438, 2011

C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 33(10): 829-834, 2013

Telomerase gene mutation screening and telomere overhang detection in Chinese patients with acute myeloid leukemia. Leukemia & Lymphoma 54(7): 1437-1441, 2014

BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients. Genetic Testing and Molecular Biomarkers 17(2): 170-173, 2013